China accepts CANbridge’s NDA for CAN108 to treat cholestatic pruritus in PFIC

CAN108 is intended for the treatment of cholestatic pruritus in patients aged two months and above with progressive familial intrahepatic cholestasis. Credit: Nephron/ commons.wikimedia.org.